| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 28 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 28 |
| 2 | TACROLIMUS OINTMENT 0.1% | 28 |
| 3 | CLARITHROMYCIN | 23 |
| 4 | PREDNISONE | 23 |
| 5 | ARIPIPRAZOLE | 22 |
| 6 | ARIPIPRAZOLE ORAL | 22 |
| 7 | ARIPIPRAZOLE ORALLY DISINTEGRATING | 22 |
| 8 | CEFTAZIDIME | 22 |
| 9 | LINEZOLID | 22 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CEFOXITIN SODIUM | 4 | 0.0029 |
| 1 | AMIKACIN SULFATE | 5 | 0.0029 |
| 2 | CEFTAZIDIME | 22 | 0.0028 |
| 3 | VANCOMYCIN HYDROCHLORIDE | 21 | 0.0025 |
| 4 | IMIPENEM AND CILASTATIN SODIUM | 5 | 0.0024 |
| 5 | CEFAZOLIN SODIUM | 16 | 0.0013 |
| 6 | CLOFAZIMINE | 8 | 0.0012 |
| 7 | MOXIFLOXACIN HYDROCHLORIDE | 21 | 0.0010 |
| 8 | AMIKACIN | 17 | 0.0010 |
| 9 | LINEZOLID | 22 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 30 |
| 1 | Azole Antifungal [EPC] | 24 |
| 2 | Macrolide Antimicrobial [EPC] | 23 |
| 3 | Atypical Antipsychotic [EPC] | 22 |
| 4 | Oxazolidinone Antibacterial [EPC] | 22 |
| 5 | Central Nervous System Stimulant [EPC] | 21 |
| 6 | Glycopeptide Antibacterial [EPC] | 21 |
| 7 | Fluoroquinolone Antibacterial [EPC] | 18 |
| 8 | Tetracycline-class Drug [EPC] | 18 |
| 9 | Aminoglycoside Antibacterial [EPC] | 17 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Oxazolidinone Antibacterial [EPC] | 22 | 0.0007 |
| 1 | Tetracycline-class Antibacterial [EPC] | 4 | 0.0005 |
| 2 | Macrolide Antimicrobial [EPC] | 23 | 0.0004 |
| 3 | Aminoglycoside Antibacterial [EPC] | 17 | 0.0004 |
| 4 | Phosphate Binder [EPC] | 1 | 0.0003 |
| 5 | Antimycobacterial [EPC] | 8 | 0.0003 |
| 6 | Glycopeptide Antibacterial [EPC] | 21 | 0.0003 |
| 7 | Tetracycline-class Drug [EPC] | 18 | 0.0003 |
| 8 | Central Nervous System Stimulant [EPC] | 21 | 0.0002 |
| 9 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 5 | 0.0002 |